The apoptosis of granulosa cells is involved in follicular atresia and degeneration of the corpus luteum. The mechanisms that regulate follicular atresia and luteal degeneration remain obscure. Survivin is a member of the family of inhibitors of apoptosis protein that is expressed during fetal development and in cancer tissues. The present study investigates the expression of survivin, as well as its regulation and function in granulosa cells. We identified survivin at the protein level in granulosa cells and detected not only survivin but also splice-variant transcripts in human and mouse granulosa-luteal cells. One-step real-time PCR analysis revealed that HCG increases the amount of survivin mRNA expressed in cultured human granulosa cells. These results suggest that survivin is involved in supporting luteal function, and that HCG contributes to this role.
Introduction
Apoptosis is a physiological process that is essential to the normal embryonic development and adult tissue homeostasis. Survivin is an inhibitor of apoptosis protein (Ambrosini et al., 1997 ) that directly interacts with several caspases to inhibit apoptosis (Shin et al., 2001) and also functions as a chromosomal passenger protein during chromosomal segregation (Adams et al., 2001) . The expression of human survivin is regulated in a strict cell cycle-dependent manner with levels reaching a maximum during the G2/M phase and its anti-apoptotic function is mediated both by its BIR domain and by the interaction of its C-terminal coiled-coil domain with microtubules of the mitotic spindle (Adida et al., 1998a,b; Ambrosini et al., 1998; Li et al., 1998a,b) . Survivin probably plays a prominent role in regulating apoptosis during normal development because several human fetal tissues express this protein (Adida et al., 1998a,b) .
The mouse survivin gene is transcribed into three alternatively spliced variants, named survivin 40, survivin 121, and survivin 140 (Conway et al., 2000) . Survivin 140 consists of all four exons. Survivin 40 lacks sequences derived from exon 2, leading to an in-frame stop codon, and survivin 121 is derived from exons 1 to 3 and retains part of intron 3. Each of these splice-variants has different antiapoptotic properties against apoptotic stimuli and is differentially expressed during fetal development and in adult tissues (Conway et al., 2000) . The four splice-variants in humans are survivin, survivin-2B, survivin-DEx3 and survivin-3B (Mahotka et al., 1999; Badran et al., 2004) . Survivin consists of all four exons, and survivin-2B has an additional exon (exon 2B) inserted between exons 2 and 3. Survivin-DEx3 lacks exon 3 as well as a frame shift with an extension of the reading frame into the open reading frame of the 3 0 untranslated region (Mahotka et al., 1999) . Survivin-3B consists of all four exons plus the novel exon 3B that is flanked by exons 3 and 4 (Badran et al., 2004) . These splice-variants have different functions and properties in the regulation of apoptosis.
We previously showed that survivin mRNA and protein are expressed in mouse pre-implantation embryos and that it could protect the embryos from apoptosis by inhibiting a caspase-mediated apoptotic pathway (Kawamura et al., 2003) . A recent study has demonstrated that survivin mRNA and protein are expressed in hen granulosa and theca tissue, and that the levels of survivin mRNA during follicular development are highest in granulosa cells from the prehierarchal follicles (Johnson et al., 2002) .
Most ovarian follicles undergo atresia, a hormonally controlled apoptotic process (Kaipia and Hsueh, 1997) . Follicles become atretic, the corpus luteum degenerates via apoptosis , Ca 2þ /Mg 2þ -dependent endonuclease activity is activated and apoptotic DNA undergoes fragmentation in ovarian granulosa and luteal cells (Zeleznik et al., 1989; Dharmarajan et al., 1994) .
The present study establishes the presence of survivin in human and mouse granulosa cells and determines whether gonadotrophins stimulate survivin levels in these cells.
Materials and methods

Animals and sample collection
Immature 4-week-old female IVCS mice (Institute for Animal Reproduction, Ibaragi, Japan) were injected with 10 IU of pregnant mare serum gonadotrophin (Sigma, St Louis, MO) followed by 10 IU of HCG (Sigma) 48 h later. Twenty-four hours after the HCG injection, the ovaries were removed and the granulosa-luteal cells were excised under a microscope using a 26-gauge needle as described (Thordarson et al., 1997; Corambula et al., 2002) . All procedures involving the care and use of animals were approved by the animal research committee at Akita University School of Medicine.
Culture of human granulosa-luteal cells
Women who underwent follicle aspiration for IVF provided written informed consent to participate in all aspects of the study according to the guidelines of our Institutional Review Board. Follicular growth was stimulated with 150,300 IU of HMG (HMG-Nikken; Nikken, Japan) daily, which was administered from the second day of menstruation together with 900 mg of a GnRH analogue (GnRHa; Buserelin: Sprecur, Mochida, Japan) administered daily from the mid-luteal phase of the previous cycle as described (Tasdemir et al., 1993 ). An i.m. injection of 10 000 IU of HCG was administered 35 h before follicular puncture. Pooled follicular fluid obtained from several IVF patients was separated by centrifugation at 3000 g for 20 min, and then pellets containing granulosa-luteal cells were suspended in phosphate-buffered saline (PBS; Sigma) containing 0.1% hyaluronidase. After incubation at 37 8C for 20 min, the cells were placed on a 50% (v/v) Percoll cushion (Pharmacia LKB Biotechnology, Piscataway, NJ) and sedimented by centrifugation at 3000 g for 30 min. The cell pellets were washed twice with PBS and suspended in serum-free GIT medium (Wako Chemicals, Osaka, Japan) containing 50 IU/ml Penicillin G and 50 mg/ml streptomycin. Approximately, 4 £ 10 4 cells/well in 200 ml of serum-free GIT medium were placed in collagen-coated 48-well plates (CelltightC1 Plate 48F; Sumitomo Bakelite Co, Tokyo, Japan) and incubated at 37 8C under 5% CO 2 in air for 48 h. Adherent cells were washed with serum free GIT medium and HCG (0, 0.01, 0.1, 1, 10 or 100 IU/ml) was added to the wells.
RT -PCR
Total RNA was extracted from mouse and human granulosa-luteal cells using the RNeasy Mini Kit (Qiagen, Valencia, CA) according to the manufacturer's instructions. The quality of RNA in the extracts was assayed and the concentration was determined using a SmartSpec spectrophotometer (Bio-Rad Laboratories, Hercules, CA). The RNA samples were reversetranscribed into cDNA and PCR proceeded as described in the legends to Table I . The primers for mouse and human survivin were based on the published sequences shown in Table I . Simultaneously amplified mouse and human placenta cDNA served as the positive control. Water was substituted for mRNA in the negative control. The PCR products were separated by 2% agarose gel electrophoresis (Agarose-LE, Nacalai Tesque, Inc., Kyoto, Japan) in the presence of ethidium bromide (Sigma) and visualized using an ultra-violet transilluminator (Funakoshi, Tokyo, Japan). To confirm the identity of the products, DNA bands were eluted from the gels using the QIAquick Gel Extraction Kit (Qiagen KK, Tokyo, Japan), ligated into the pDrive Cloning vector (Qiagen KK), and cloned according to standard protocols. Plasmid DNA was recovered using a Quantum Prep Plasmid Miniprep Kit (Bio-Rad, Hercules, CA), cycle sequenced using the BigDye Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems, Tokyo, Japan) and examined in an ABI PRISM 3100 Genetic Analyzer (Applied Biosystems) using T7 or SP6 site-specific primers.
One-step real-time quantitative RT -PCR
Real-time quantitative RT-PCR proceeded in a LightCycler System (Roche Diagnostics, Tokyo, Japan) using the QuantiTect Probe RT-PCR Kit (Qiagen, Valencia, CA) and the one-step method based on TaqMan as described (Konishi et al., 2004) . The reaction mixtures contained 10 ml of 2£QuantiTect Probe RT-PCR Master Mix, 0.2 ml Quantitect Probe RT Mix, 0.5 ml of 40 mM primer, 0.5 ml of 8 mM TaqMan probe and 2 mM template RNA adjusted to 20 ml with DNase/RNase-free water. The reaction mix was loaded into glass capillary tubes. Table II shows the primers and TaqMan probes for 18S ribosomal RNA and human survivin mRNA designed using Primer Express V1.0 software (Applied Biosystems, Foster City, CA). Conditions for the one-step real-time quantitative RT-PCR were 20 min at 50 8C (reverse transcription) and 15 min at 95 8C (RT inactivation and initial activation) followed by 35 cycles of amplification for 0 s at 95 8C (denaturation) and 1 min at 60 8C (annealing and extension). All heating and cooling steps proceeded at a slope of 20 8C/s. A single fluorescence reading at 530 nm was taken from each sample during extension.
Western blotting to detect survivin protein
Protein extracts from human and mouse granulosa-luteal cells were subjected to western blot analysis essentially as described previously and separated by SDS-PAGE using 16% polyacrylamide gels (Tefco, Tokyo, Japan). Resolved proteins were transferred to a polyvinylidene difluoride (PVDF) membrane using a Tefco electroblot apparatus and then incubated with anti-human survivin antibody overnight at 4 8C, or with horse-radish peroxidase-conjugated anti-rabbit immunoglobulin G secondary antibody for 1 h at room temperature. Immunoreactive bands were detected using Enhanced Chemiluminescence Plus Western blotting detection reagents (Amersham Biosciences, NJ). 
Immunohistochemistry
Mouse ovaries were fixed in paraformaldehyde in PBS and embedded in paraffin blocks. Serial 3 mm sections were cut, and the histopathological diagnosis was confirmed in sections stained with haematoxylin and eosin. The sections were deparaffinized in xylene, rehydrated in a graded ethanol series, quenched in 3% hydrogen peroxidase, blocked and incubated with affinitypurified anti-human survivin antibody (20 mg/ml) overnight at 4 8C. After several PBS washes, the sections were incubated with peroxidase-conjugated goat anti-rabbit immunoglobulin G (DAKO, Carpinteria, CA) for 1 h at room temperature followed by 3 0 ,3 0 -diaminobenzidine and then counterstained with haematoxylin. The primary antibody in the negative control was incubated with human survivin control peptide for 1 h at 37 8C before further processing as described above.
Statistical analysis
The results are presented as means^SEM. All data were analysed using the Mann-Whitney U test. P , 0.001 was considered statistically significant.
Results
Expression of survivin mRNA and protein
We detected mRNA for survivin in mouse and human granulosaluteal cells using RT -PCR (Figure 1 ) and two survivin bands in mouse granulosa-luteal cells. Sequencing the DNA of these bands revealed that the predicted survivin amplification product of 348 bp (survivin 140) was the larger, whereas the smaller was a 238 bp survivin fragment (survivin 40) lacking 110 bp of exon 2 between positions 3267 and 3377 as reported (Kawamura et al., 2003) . We detected three survivin bands in human granulosa-luteal cells, the largest being identical to the survivin splice-variant, survivin-2B, with the additional exon 2B. The middle band was the predicted survivin amplification product of 428 bp. The smallest band was consistent with the survivin splice-variant, survivin-DEx3 that lacks exon 3.
We identified a survivin protein of approximately 16.5 kDa in the total cellular proteins collected from human and mouse granulosaluteal cells (Figure 2 ). Our RT -PCR revealed splice variants of survivin mRNA; however, by western blotting, we could not detect other bands that correspond to those variants. One of the reasons might be due to the small molecular weight of survivin protein and the extremely low levels of survivin proteins in granulosa cells (Adida et al., 1998a,b; Krieg et al., 2002) .
Survivin expression in mouse ovaries during development
Ovarian sections from immature female mice were incubated with pregnant mare's serum gonadotrophin (PMSG) for 0, 24 and 48 h, or with PMSG/HCG for 24 h. Figure 3 shows that ovaries from immature mice contained many preantral, early antral and preovulatory follicles. Immunohistochemical staining detected survivin in mouse granulosa cells and oocytes at all stages of development, but more of it was expressed in oocytes than in granulosa cells from follicles.
Human survivin mRNA levels are up-regulated by HCG Granulosa-luteal cells were stimulated with various concentrations of HCG for 24 h to determine whether HCG enhances survivin mRNA expression. Figure 4 shows that survivin mRNA expression assessed by one-step real-time quantitative RT-PCR was significantly increased by HCG at both 10 and 100 IU/ml (5.4-fold, P , 0.001), whereas concentrations of HCG below 10 IU/ml had no effect. We analysed total RNA extracted from human granulosaluteal cells at different times after exposure to 10 IU/ml of HCG by quantitative RT -PCR. Survivin mRNA levels peaked at 8.8-fold within both 6 and 12 h of HCG incubation (P , 0.001; Figure 5 ).
Discussion
The present study demonstrated that survivin mRNA and protein are expressed in human and mouse granulosa-luteal cells. Survivin protein was expressed throughout all the developmental stages in mouse granulosa cells and embryos following gonadotrophin stimulation. Moreover, HCG significantly induced the up-regulation of survivin mRNA levels in cultured human granulosa-luteal cells.
Progesterone production by cultured cells was simultaneously and time-dependently stimulated by all tested concentrations of HCG (data not shown), findings that are consistent with those of other reports (Matsubara et al., 2000; Abraham et al., 2003) . The binding of HCG to granulosa cell membrane receptors increases cAMP levels, phosphorylates proteins and activates the protein kinase A pathway, as well as steroidogenesis (Sugino et al., 2000) . In contrast to progesterone production, survivin mRNA shows an increase in a time-dependent manner in the present study. Whether the upregulation of survivin expression by HCG is a direct or indirect action via the protein kinase A pathway remains unknown. The intracellular signalling pathway of HCG in the up-regulation of survivin mRNA also remains obscure.
Survivin was detected by immunohistochemical staining in mouse granulosa cells and oocytes at all stages of development and the oocytes were intensely stained. As indicated in the introduction, survivin protects the embryo from apoptosis by inhibiting an apoptotic pathway (Kawamura et al., 2003) . Furthermore, survivin mRNA is present at the earliest stages of Xenopus oocytes and it accumulates during oogenesis. It is also present in early Xenopus embryos and after the onset of zygotic transcripts, the amount of survivin mRNA rapidly declines to undetectable levels (Murphy et al., 2002) . Survivin-null mouse embryos show embryonic lethality (Uren et al., 2000) . These studies indicate that survivin is necessary for the oocytes and high levels should be expressed.
Several factors might control the apoptosis of granulosa cells. Gonadotrophins, epidermal growth factor/transforming growth factor-a, basic fibroblast growth factor, insulin-like growth factor I, estrogens and Fas ligand are known survival factors Chun et al., 1995; Quirk et al., 1995; Kaipia et al., 1996) . The inhibitors of apoptosis proteins, Xiap and Hiap-2 are expressed in rat granulosa cells of preovulatory follicles after HCG stimulation (Leung and Steele, 1992) . Gonadotrophin increases the Xiap and Hiap-2 protein content and high levels of antiapoptotic gene expression confer protection against apoptosis. Bcl-2 is also expressed in human and rat luteal cells and HCG significantly increases Bcl-2 mRNA and protein levels (Tilly et al., 1995; Yuan wei and Giudice, 1997) . We found here that survivin is expressed at basal levels in granulosa cells and that HCG up-regulates survivin . Levels of survivin mRNA in cultured human granulosa-luteal cells before (0 h) and after adding HCG. Total RNA was isolated from cells initially cultured and then incubated for 0 (before), 1, 3, 6, 12 and 24 h in serum-free GIT medium containing 10 IU/ml of HCG. Expression levels of survivin mRNA in total RNA determined by one-step real-time quantitative RT-PCR were normalized with 18S ribosomal RNA levels. These data are calculated as means of four experiments. Bar represents SEM. *, P , 0.001 versus control. mRNA levels. HCG prevents the spontaneous apoptotic DNA fragmentation of cultured rat preovulatory follicles or rabbit corpus luteum (Chun et al., 1994; Dharmarajan et al., 1994) . These observations suggest that HCG functions as an antiapoptotic factor in the human corpus luteum and that the role of survivin is consistent with its potential function in luteal regression.
Similar to the findings of a previous study that demonstrated the time-dependent onset of apoptosis of the rabbit corpus luteum in vitro, DNA started to disintegrate as early as 30 min after culture initiation and reached maximal levels within 8 h of incubation (Dharmarajan et al., 1994) . Our data indicated that survivin mRNA reached a maximal level within 6 h of the HCG incubation and continued for a further 24 h. We speculate that a significant increase in the amount of survivin affects the maintenance of granulosa-luteal cell survival.
The levels of survivin mRNA expression are higher in granulosa cells from undifferentiated, prehierarchal hen follicles compared with differentiated, preovulatory follicles, and decrease during the early stages of atresia (Johnson et al., 2002) . The present study did not address the developmental expression of survivin. However, HCG rescues antral and preovulatory follicles from atresia (Kaipia and Hsueh, 1997) and up-regulates survivin expression, indicating that survivin is a survival factor for granulosa cells.
In summary, this study demonstrated that the survivin mRNA and protein are expressed in mouse and human granulosa cells during follicular development and that HCG induces their up-regulation. Therefore, survivin might help support luteal function by suppressing apoptosis and HCG might contribute to survivin expression. Further studies should clarify the molecular mechanisms of survivin underlying the action of gonadotrophin as a survival factor in suppressing granulosa cell apoptosis.
